Paroxetine HCl 78246-49-8
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight: 365.83 Paroxetine HCl is an antidepressant drug of the SSRI type.
Paroxetine apparently exerts their antidepressant activity by increasing
the concentration of 5-HT in the extracellular compartment, thereby
enhancing serotoninergic neurotransmission. Paroxetine (1-300 μM)
results in a concentration-dependent reduction in the firing rate of DRN
serotoninergic neurons with IC50 values of 1.4 μM in the ACSF
superfusing brain stem slices. Paroxetine is a highly
Potent Inhibitor of desipramine hydroxylation, the inhibition constant
(Ki) value of 2.0 mM indicated greater inhibiting potency than
fluoxetine or norfluoxetine.
Paroxetine is shown to be a
potent (Ki = 1.1 nM) and specific inhibitor of [3H]-5-hydroxytryptamine
(5-HT) uptake into rat cortical and hypothalamic synaptosomes in vitro.
Paroxetine demonstrates weak affinity for muscarinic receptors (Ki = 89
nM) but is at least 15 fold weaker than amitriptyline (Ki = 5.1 nM). Paroxetine inactivates CYP2D6 via the formation of a metabolite intermediate complex.
Paroxetine produces a dose-related inhibition of [3H]-5-HT uptake (ED50 =
1.9 mg/kg) into rat hypothalamic synaptosomes ex vivo with little
effect on [3H]-l-noradrenaline (NA) uptake (ED50 greater than 30 mg/kg).
Paroxetine (ED50 1-3 mg/kg PO) prevents the 5-HT depleting effect of
p-chloroamphetamine (PCA) in rat brain, demonstrating 5-HT uptake
blockade in vivo.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Chemical Information
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on 78246-49-8. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Paroxetine HCl 78246-49-8、78246-49-8 Paroxetine HCl. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight: 365.83 Paroxetine HCl is an antidepressant drug of the SSRI type.
Paroxetine apparently exerts their antidepressant activity by increasing
the concentration of 5-HT in the extracellular compartment, thereby
enhancing serotoninergic neurotransmission. Paroxetine (1-300 μM)
results in a concentration-dependent reduction in the firing rate of DRN
serotoninergic neurons with IC50 values of 1.4 μM in the ACSF
superfusing brain stem slices. Paroxetine is a highly
Potent Inhibitor of desipramine hydroxylation, the inhibition constant
(Ki) value of 2.0 mM indicated greater inhibiting potency than
fluoxetine or norfluoxetine.
Paroxetine is shown to be a
potent (Ki = 1.1 nM) and specific inhibitor of [3H]-5-hydroxytryptamine
(5-HT) uptake into rat cortical and hypothalamic synaptosomes in vitro.
Paroxetine demonstrates weak affinity for muscarinic receptors (Ki = 89
nM) but is at least 15 fold weaker than amitriptyline (Ki = 5.1 nM). Paroxetine inactivates CYP2D6 via the formation of a metabolite intermediate complex.
Paroxetine produces a dose-related inhibition of [3H]-5-HT uptake (ED50 =
1.9 mg/kg) into rat hypothalamic synaptosomes ex vivo with little
effect on [3H]-l-noradrenaline (NA) uptake (ED50 greater than 30 mg/kg).
Paroxetine (ED50 1-3 mg/kg PO) prevents the 5-HT depleting effect of
p-chloroamphetamine (PCA) in rat brain, demonstrating 5-HT uptake
blockade in vivo.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Chemical Information
Molecular Weight (MW) | 365.83 |
---|---|
Formula | C19H20FNO3.HCl |
CAS No. | 78246-49-8 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | |
Solubility (25°C) * | In vitro | DMSO | 73 mg/mL (199.54 mM) |
---|---|---|---|
Water | 10 mg/mL (27.33 mM) | ||
Ethanol | 35 mg/mL (95.67 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine, hydrochloride (1:1) |
---|
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on 78246-49-8. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Paroxetine HCl 78246-49-8、78246-49-8 Paroxetine HCl. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Neuronal Signaling > AChR Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9